ESMO 2024 - Henar Hevia & Carolyn Sousa

ESMO 2024 was chock full of oncological data, diverse presentations providing hope across the cancer spectrum from breast and lung to unmet needs in colorectal and bladder.

So it was that pharmaphorum web editor Nicole Raleigh spoke with Johnson & Johnson’s Henar Hevia, senior director, EMEA therapeutic area lead, oncology, and Carolyn Sousa, regional commercial strategy lead, EMEA region, solid tumour oncology, discussing the company’s new data presentations and the congress more generally.

With a three-decade-plus journey in the oncology space, Hevia and Sousa spoke to the company’s developments in lung, bladder, and colorectal cancer, as announced at both ESMO and WCLC, as well as what might be coming next for the field.

Watch the video below to learn more, and be sure to catch up on earlier ESMO 2024 conversations with EVERSANA, Regeneron, and Illumina.